Leading venous specialist Stephen Black (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) analyses the burgeoning venous stenting landscape during a sit-down with Venous News during CX 2026. Black touches on the trial behind recent approvals of the Gore Viabhan Fortegra venous stent for use in the treatment of symptomatic inferior vena cava (IVC) and iliofemoral venous outflow obstruction in both the USA and Europe, new C-TRACT data showing “significant benefit” for venous stents in chronic post-thrombotic syndrome (PTS), and emerging promise for a bioresorbable stent in the venous space.











